We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.71%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$2.38B
AUM Growth
+$16.2M
(+0.69%)
Cap. Flow
-$65.9M
Cap. Flow
% of AUM
-2.78%
Top 10 Holdings %
Top 10 Hldgs %
48.01%
Holding
72
New
8
Increased
36
Reduced
21
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$33M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
+$27.8M |
| 3 |
Pfizer
PFE
|
+$24.4M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$13.8M |
| 5 |
AGN
Allergan Inc
AGN
|
+$13.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$71.4M |
| 2 |
Illumina
ILMN
|
+$44.1M |
| 3 |
SHPG
Shire pic
SHPG
|
+$39.5M |
| 4 |
Merck
MRK
|
+$37.9M |
| 5 |
Gilead Sciences
GILD
|
+$18.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cigna
CI
$78.6B
| $9.36M | 0.39% |
103,164
+18,332
| +22% | +$1.71M |
|
52
Amphastar Pharmaceuticals
AMPH
$886M
| $7.69M | 0.32% |
+660,232
| New | +$6.88M |
|
|
NVO
53
Novo Nordisk
NVO
$225B
| $7.01M | 0.3% |
294,370
+35,350
| +14% | +$813K |
|
54
Inogen
INGN
$174M
| $5.18M | 0.22% |
251,600
-29,600
| -11% | -$601K |
|
|
CBAY
55
DELISTED
Cymabay Therapeutics
CBAY
| $4.85M | 0.2% |
+708,585
| New | +$4.35M |
|
56
Novartis
NVS
$303B
| $3.92M | 0.16% |
46,426
+7,701
| +20% | +$623K |
|
|
AMBI
57
DELISTED
Ambit Biosciences Corp
AMBI
| $2.25M | 0.09% |
+146,111
| New | +$1M |
|
|
IMDZ
58
DELISTED
Immune Design Corp.
IMDZ
| $1.68M | 0.07% |
+95,000
| New | +$1.2M |
|
59
Tandem Diabetes Care
TNDM
$1.21B
| $1.36M | 0.06% |
10,142
+4,619
| +84% | +$647K |
|
|
CARM
60
DELISTED
Carisma Therapeutics
CARM
| $1.25M | 0.05% |
+5,624
| New | +$1.34M |
|
61
ProQR Therapeutics
PRQR
$243M
| $1.2M | 0.05% |
+70,000
| New | +$1.12M |
|
|
FOLD
62
DELISTED
Amicus Therapeutics
FOLD
| $1.19M | 0.05% |
+200,000
| New | +$1.05M |
|
|
ALDR
63
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.13M | 0.05% |
89,300
+48,775
| +120% | +$737K |
|
|
RNA
64
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
| $794K | 0.03% |
94,184
+18,350
| +24% | +$174K |
|
|
WX
65
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $661K | 0.03% |
18,873
+5,680
| +43% | +$195K |
|
|
ANTH
66
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $476K | 0.02% |
30,995
+3,544
| +13% | +$74.6K |
|
67
Accuray
ARAY
$29.1M
| – | – |
-491,505
| Closed | -$4.33M |
|
|
68
Illumina
ILMN
$28.8B
| – | – |
-253,699
| Closed | -$44.1M |
|
69
Ironwood Pharmaceuticals
IRWD
$627M
| – | – |
-430,704
| Closed | -$5.53M |
|
|
70
Merck
MRK
$329B
| – | – |
-686,002
| Closed | -$37.9M |
|
71
Theravance Biopharma
TBPH
$876M
| – | – |
-152,151
| Closed | -$4.85M |
|
|
CLVS
72
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-314,952
| Closed | -$13M |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
AAA
TGM
Sectoral Asset Management's Q3 2014 Portfolio in Review
As of Q3 2014, Sectoral Asset Management held 72 positions worth $2.38B, up 0.69% from $2.36B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Sectoral Asset Management's Q3 2014 filing shows 8 new, 36 increased, 21 reduced and 6 closed positions. Its largest new stake was Pfizer: 868,442 shares worth $24.4M. The largest sale was Vertex Pharmaceuticals, an estimated $71.4M.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 90% a quarter earlier.
- Sectoral Asset Management's largest Q3 2014 buy was Pfizer: 868,442 shares worth $24.4M.
- Sectoral Asset Management added most to Viatris in Q3 2014, an estimated $33M increase.
- Sectoral Asset Management's biggest Q3 2014 reduction was Vertex Pharmaceuticals, cutting an estimated $71.4M.
- Sectoral Asset Management fully exited Illumina in Q3 2014, selling an estimated $44.1M.
- Sectoral Asset Management's ten largest holdings make up 48% of its $2.38B portfolio in Q3 2014.
- Sectoral Asset Management opened 8 new positions and closed 6 in Q3 2014.
- Sectoral Asset Management's portfolio value rose 0.69% quarter-over-quarter to $2.38B.
Based on Sectoral Asset Management's 13F filing for Q3 2014, filed 13 Nov 2014.